Modern antiretroviral treatments delay disease progression and death and create the possibility for HIV+ individuals to live near-normal life-spans. However, the treatments only partial restore immune function, have unknown long-term (>10 year) toxicities, and likely only partially reverse damage done by the virus prior to the initiation of therapy. The critical question that arises is how will clinicians maximize treatment success and minimize treatment and disease-associated long term toxicities? To answer this question, investigators need access to clinical outcome information that is tightly linked to biologic specimens and socio-biologic data to enable translational research. The CFAR Network of Integrated Clinical Systems (CNICS) project is a new resource that can contribute substantially to the contemporary HIV research agenda. Established in 2002 and funded as an R24 research platform in 2006, CNICS is a clinic-based research network that reflects the outcomes of clinical decisions and management options used in the care of HIV infected individuals at 8 CFAR sites: UAB, U Washington, UCSF, UCSD, Case Western Reserve, Fenway Community Clinic (Brown/Harvard), U North Carolina, and Johns Hopkins. The CNICS project supports a database that serves as a central repository of verified and quality-controlled data from the electronic medical records (EMRs) at each site. The clinical data is linked to patient reported outcome obtained at regular intervals, geospatial data, and to biologic specimens stored in repositories and readily available for use in translational research projects. The mission of CNICS is to provide access to the specimen and data repository to any investigator who submits an approved concept proposal. In this fashion, CNICS is a 'peer-reviewed open access'research platform available to investigators worldwide.
The specific aims for this competitive renewal of CNICS are to: 1: Expand the original CNICS research platform;2: Provide direct access to the expanded CNICS research platform to as many investigators as feasible;and 3: Establish a Mentoring Program that targets early and mid-career investigators engaged in multidisciplinary HIV-focused research.
|Solorio, R; Ayala, N C; Paez, E et al. (2016) Use of Cognitive Interviews to Adapt PROMIS Measurement Items for Spanish Speakers Living with HIV. AIDS Res Treat 2016:8340863|
|Rachlis, Beth; Karwa, Rakhi; Chema, Celia et al. (2016) Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Saf 39:959-76|
|Keating, Sheila M; Kassanjee, Reshma; Lebedeva, Mila et al. (2016) Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence. J Acquir Immune Defic Syndr 73:581-588|
|Buchacz, Kate; Lau, Bryan; Jing, Yuezhou et al. (2016) Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. J Infect Dis 214:862-72|
|Caniglia, Ellen C; Sabin, Caroline; Robins, James M et al. (2016) When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study. J Acquir Immune Defic Syndr 72:214-21|
|Edwards, Todd C; Fredericksen, Rob J; Crane, Heidi M et al. (2016) Content validity of Patient-Reported Outcomes Measurement Information System (PROMIS) items in the context of HIV clinical care. Qual Life Res 25:293-302|
|Chander, Geetanjali; Monroe, Anne K; Crane, Heidi M et al. (2016) HIV primary care providers--Screening, knowledge, attitudes and behaviors related to alcohol interventions. Drug Alcohol Depend 161:59-66|
|Shepherd, Bryan E; Liu, Qi; Mercaldo, Nathaniel et al. (2016) Comparing results from multiple imputation and dynamic marginal structural models for estimating when to start antiretroviral therapy. Stat Med 35:4335-4351|
|Klein, Marina B; Althoff, Keri N; Jing, Yuezhou et al. (2016) Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Clin Infect Dis 63:1160-1167|
|Koethe, John R; Jenkins, Cathy A; Lau, Bryan et al. (2016) Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr 73:197-204|
Showing the most recent 10 out of 231 publications